课题基金 / 基金详情

DNA methylation predicts response of triple-negative breast cancer to all-trans retinoic acid treatment

DNA methylation predicts response of triple-negative breast cancer to all-trans retinoic acid treatment
DNA甲基化预测三阴性乳腺癌对全反式视黄酸治疗的反应
批准号:
368198
负责人:
Coyle Krysta M
金额:
$0.07万
依托单位国家:
加拿大
项目类别:
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-07-01 至 2018-07-01
关键词:

项目摘要

项目成果

Coyle Krysta M的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have identified a new approach to select breast cancer patients who will benefit from treatment with an existing drug, retinoic acid. This research will have important benefits for patients with an aggressive type of breast cancer known as triple-negat
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing RNA regulation in B lymphocytes
Functional characterization of regulatory mutations in mantle cell lymphoma
Characterizing expression and function of the tumor suppressor gene RARRES1 in the differentiation hierarchy of breast cancer
Improving the efficacy of retinoic-acid-based therapies in triple-negative breast cancer
  • 批准号:
    317861
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $7.65万
  • 财政年份:
    2014
  • 负责人:
    Coyle Krysta M
  • 依托单位: